Nanodiamond Integration into Niosomes as an Emerging and Efficient Gene Therapy Nanoplatform for Central Nervous System Diseases
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
High Resolution Image Download MS PowerPoint Slide Nanodiamonds (NDs) are promising materials for gene delivery because of their unique physicochemical and biological features, along with their possibility of combination with other nonviral systems. Our aim was to evaluate the biophysical performance of NDs as helper components of niosomes, named nanodiasomes, to address a potential nonviral gene delivery nanoplatform for therapeutic applications in central nervous system (CNS) diseases. Nanodiasomes, niosomes, and their corresponding complexes, obtained after genetic material addition at different ratios (w/w), were evaluated in terms of physicochemical properties, cellular uptake, intracellular disposition, biocompatibility, and transfection efficiency in HEK-293 cells. Nanodiasomes, niosomes, and complexes fulfilled the physicochemical features for gene therapy applications. Biologically, the incorporation of NDs into niosomes enhanced 75% transfection efficiency ( p < 0.001) and biocompatibility ( p < 0.05) to values over 90%, accompanied by a higher cellular uptake ( p < 0.05). Intracellular trafficking analysis showed higher endocytosis via clathrins ( p < 0.05) in nanodiaplexes compared with nioplexes, followed by higher lysosomal colocalization ( p < 0.05), that coexisted with endosomal escape properties, whereas endocytosis mediated by caveolae was the most efficient pathway in the case of nanodiaplexes. Moreover, studies in CNS primary cells revealed that nanodiaplexes successfully transfected neuronal and retinal cells. This proof-of-concept study points out that ND integration into niosomes represents an encouraging nonviral nanoplatform strategy for the treatment of CNS diseases by gene therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Niosomes, which are comprised of uncharged single-chain surfactant and cholesterol94,95 have also shown limited success potential as non-viral gene delivery systems96–101 due to improved transfection efficiency, biocompatibility, and cellular uptake, in addition to effects on intracellular trafficking.102”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [102]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NIH Image to ImageJ: 25 years of image analysis
Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012) · Nature Methods · doi:10.1038/nmeth.2089 · Cited by 64,638
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,828
Computer Visualization of Three-Dimensional Image Data Using IMOD
Kremer, J. R., Mastronarde, D. N., & McIntosh, J. R. (1996) · Journal of Structural Biology · doi:10.1006/jsbi.1996.0013 · Cited by 5,611
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123
The properties and applications of nanodiamonds
Mochalin, V. N., Shenderova, O., Ho, D., & Gogotsi, Y. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2011.209 · Cited by 2,745
Collins, T. J. (2007) · BioTechniques · doi:10.2144/000112517 · Cited by 2,124 · cited 3×
“Images were examined with ImageJ software.”
InfluentialEndosomal escape pathways for delivery of biologicals
Varkouhi, A. K., Scholte, M., Storm, G., & Haisma, H. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.004 · Cited by 1,561
Solid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,495
Dunbar, C. E., High, K. A., Joung, J. K., Kohn, D. B., Ozawa, K., & Sadelain, M. (2018) · Science · doi:10.1126/science.aan4672 · Cited by 1,410
Engineering adeno-associated virus vectors for gene therapy
Li, C., & Samulski, R. J. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-019-0205-4 · Cited by 1,175
Therapeutic in vivo gene transfer for genetic disease using AAV: Progress and challenges
Mingozzi, F., & High, K. A. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2988 · Cited by 893
Hagen, W. J. H., Wan, W., & Briggs, J. A. G. (2017) · Journal of Structural Biology · doi:10.1016/j.jsb.2016.06.007 · Cited by 806
In Vivo Imaging and Toxicity Assessments of Fluorescent Nanodiamonds in Caenorhabditis elegans
Mohan, N., Chen, C.-S., Hsieh, H.-H., Wu, Y.-C., & Chang, H.-C. (2010) · Nano Letters · doi:10.1021/nl1021909 · Cited by 558
Endocytosis: The Nanoparticle and Submicron Nanocompounds Gateway into the Cell
Manzanares, D., & Ceña, V. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12040371 · Cited by 488 · cited 2×
“50 In this work, we did not observe a predominant endocytic pathway when using nanodiaplexes or nioplexes, but our data suggested that the fi rst ones tra ffi cked more by CME than nioplexes (Figure 7,BA).”
The Biocompatibility of Nanodiamonds and Their Application in Drug Delivery Systems
Zhu, Y., Li, J., Li, W., Zhang, Y., Yang, X., Chen, N., Sun, Y., Zhao, Y., Fan, C., & Huang, Q. (2012) · Theranostics · doi:10.7150/thno.3627 · Cited by 396 · cited 1×
“42 Although promising, these results represent a proof-of-concept and further studies in animal models would be required for corroborating the observed potential of nanodiasomes for gene delivery.”
Polymer-Functionalized Nanodiamond Platforms as Vehicles for Gene Delivery
Zhang, X.-Q., Chen, M., Lam, R., Xu, X., Osawa, E., & Ho, D. (2009) · ACS Nano · doi:10.1021/nn900865g · Cited by 395
Niosomes: Novel sustained release nonionic stable vesicular systems — An overview
Mahale, N. B., Thakkar, P. D., Mali, R. G., Walunj, D. R., & Chaudhari, S. R. (2012) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2012.08.002 · Cited by 383
van Steensel, B., van Binnendijk, E. P., Hornsby, C. D., van der Voort, H. T. M., Krozowski, Z. S., de Kloet, E. R., & van Driel, R. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.4.787 · Cited by 357
Endocytosis of Gene Delivery Vectors: From Clathrin-dependent to Lipid Raft-mediated Endocytosis
El-Sayed, A., & Harashima, H. (2013) · Molecular Therapy · doi:10.1038/mt.2013.54 · Cited by 345 · cited 1×
“52,53 Further tra ffi cking studies extending to the late endosomal compartment were carried out.”
Lentiviral Vectors in Gene Therapy: Their Current Status and Future Potential
Escors, D., & Breckpot, K. (2010) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-010-0063-4 · Cited by 344
Karmali, P. P., & Chaudhuri, A. (2007) · Medicinal Research Reviews · doi:10.1002/med.20090 · Cited by 289
Fast tomographic reconstruction on multicore computers
Agulleiro, J. I., & Fernandez, J. J. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btq692 · Cited by 260
Niosomes, an alternative for liposomal delivery
Bartelds, R., Nematollahi, M. H., Pols, T., Stuart, M. C. A., Pardakhty, A., Asadikaram, G., & Poolman, B. (2018) · PLOS ONE · doi:10.1371/journal.pone.0194179 · Cited by 251
Nanodiamonds: The intersection of nanotechnology, drug development, and personalized medicine
Ho, D., Wang, C.-H. K., & Chow, E. K.-H. (2015) · Science Advances · doi:10.1126/sciadv.1500439 · Cited by 242
Chauhan, S., Jain, N., & Nagaich, U. (2020) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2019.09.003 · Cited by 238
Nanodiamond as a Vector for siRNA Delivery to Ewing Sarcoma Cells
Alhaddad, A., Adam, M., Botsoa, J., Dantelle, G., Perruchas, S., Gacoin, T., Mansuy, C., Lavielle, S., Malvy, C., Treussart, F., et al. (2011) · Small · doi:10.1002/smll.201101193 · Cited by 231
Nanodiamonds and Their Applications in Cells
Chipaux, M., van der Laan, K. J., Hemelaar, S. R., Hasani, M., Zheng, T., & Schirhagl, R. (2018) · Small · doi:10.1002/smll.201704263 · Cited by 221
Karami, P., Salkhi Khasraghi, S., Hashemi, M., Rabiei, S., & Shojaei, A. (2019) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2019.04.006 · Cited by 165
Analysis of Plasmid DNA from a Pharmaceutical Perspective
Russell Middaugh, C., Evans, R. K., Montgomery, D. L., & Casimiro, D. R. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970367a · Cited by 153
Mochizuki, S., Kanegae, N., Nishina, K., Kamikawa, Y., Koiwai, K., Masunaga, H., & Sakurai, K. (2013) · Biochimica et Biophysica Acta · doi:10.1016/j.bbamem.2012.10.017 · Cited by 129
Zhang, Z., Niu, B., Chen, J., He, X., Bao, X., Zhu, J., Yu, H., & Li, Y. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.02.024 · Cited by 127
Influence of plasmid DNA topology on the transfection properties of DOTAP/DOPE lipoplexes
Remaut, K., Sanders, N. N., Fayazpour, F., Demeester, J., & Smedt, S. C. D. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.009 · Cited by 110
Delgado, D., del Pozo‐Rodríguez, A., Solinís, M. Á., & Rodríguez‐Gascón, A. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.06.005 · Cited by 104
Liu, F., Yang, J., Huang, L., & Liu, D. (1996) · Pharmaceutical Research · doi:10.1023/a:1016480421204 · Cited by 103
Grijalvo, S., Puras, G., Sesma, J. Z., Sainz-Ramos, M., Qtaish, N. A., López-Méndez, T. B., Mashal, M., Attia, N., Díaz, D. D., Pons, R., et al. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020050 · Cited by 101
Self-citationSelf Assembly of DNA Nanoparticles with Polycations for the Delivery of Genetic Materials into Cells
Hosseinkhani, H., & Tabata, Y. (2006) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2006.507 · Cited by 78 · cited 1×
“48 Some mean dispersity values were slightly high, as is the case of niosomes/nioplexes and nanodiaplexes at the 5/1 ratio (Figure 2B), which could be due to the presence of few aggregates in the sample, denoted by the presence of a high peak in the particle size-distribution intensity at the…”
Ojeda, E., Puras, G., Agirre, M., Zarate, J., Grijalvo, S., Eritja, R., Martinez-Navarrete, G., Soto-Sánchez, C., Diaz-Tahoces, A., Aviles-Trigueros, M., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.11.017 · Cited by 74
Self-citationClathrin-Mediated Endocytosis and Adaptor Proteins
Popova, N. V., Deyev, I. E., & Petrenko, A. G. (2013) · Acta Naturae · doi:10.32607/20758251-2013-5-3-62-73 · Cited by 71 · cited 1×
“54 These results are in accordance with a previous but more basic intracellular tra ffi cking study of fl uorescent NDs which reported their internalization in early endosomes followed by lysosomal localization.”
Current Status and Challenges Associated with CNS-Targeted Gene Delivery across the BBB
Kimura, S., & Harashima, H. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121216 · Cited by 65
Intracellular Trafficking of Fluorescent Nanodiamonds and Regulation of Their Cellular Toxicity
Prabhakar, N., Khan, M. H., Peurla, M., Chang, H., Hanninen, P. E., & Rosenholm, J. M. (2017) · ACS Omega · doi:10.1021/acsomega.7b00339 · Cited by 62
We still have a Long Way to go to Effectively Deliver Genes!
Pezzoli, D., Chiesa, R., Nardo, L. D., & Candiani, G. (2012) · Journal of Applied Biomaterials & Functional Materials · doi:10.5301/jabfm.2012.9707 · Cited by 61
Lim, D. G., Rajasekaran, N., Lee, D., Kim, N. A., Jung, H. S., Hong, S., Shin, Y. K., Kang, E., & Jeong, S. H. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b09624 · Cited by 61
Zhao, L., Nakae, Y., Qin, H., Ito, T., Kimura, T., Kojima, H., Chan, L., & Komatsu, N. (2014) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.10.64 · Cited by 58
AL Qtaish, N., Gallego, I., Villate-Beitia, I., Sainz-Ramos, M., López-Méndez, T. B., Grijalvo, S., Eritja, R., Soto-Sánchez, C., Martínez-Navarrete, G., Fernández, E., et al. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030198 · Cited by 57
Self-citationWang, F., & Liu, J. (2013) · Nanoscale · doi:10.1039/c3nr04143c · Cited by 53 · cited 3×
“45 In this regard, relevant physicochemical parameters of nonviral vectors, such as size, zeta potential, shape, and rigidity seem to a ff ect the internalization process and posterior intracellular pathway followed by the nanoparticle and the genetic material.”
InfluentialGallego, I., Villate-Beitia, I., Martínez, G., Menéndez, M., López-Méndez, T. B., Soto‐Sánchez, C., Sesma, J. Z., Puras, G., Fernández, E., & Pedraz, J. L. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.12.018 · Cited by 52
Self-citationKim, H., Man, H., Saha, B., Kopacz, A. M., Lee, O., Schatz, G. C., Ho, D., & Liu, W. K. (2012) · The Journal of Physical Chemistry Letters · doi:10.1021/jz301756e · Cited by 48
Badea, I., Alwani, S., Kaur, R., Michel, D. L., Chitanda, J. M., Verrall, R. E., & Karunakaran, C. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s92218 · Cited by 43
Villate-Beitia, I., Gallego, I., Martínez-Navarrete, G., Zárate, J., López-Méndez, T., Soto-Sánchez, C., Santos-Vizcaíno, E., Puras, G., Fernández, E., & Pedraz, J. L. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.07.035 · Cited by 42
Self-citationNon‐viral retinal gene therapy: a review
Issa, P. C., & MacLaren, R. E. (2012) · Clinical & Experimental Ophthalmology · doi:10.1111/j.1442-9071.2011.02649.x · Cited by 39 · cited 1×
“8 However, their low transfection e ffi ciency represents the most important handicap for clinical applications.”
Ojeda, E., Puras, G., Agirre, M., Zarate, J., Grijalvo, S., Eritja, R., DiGiacomo, L., Caracciolo, G., & Pedraz, J.-L. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.02.043 · Cited by 38
Self-citationMashal, M., Attia, N., Soto‐Sánchez, C., Martínez, G., Fernández, E., Puras, G., & Pedraz, J. L. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.09.038 · Cited by 37
Self-citationSun, Y., Lv, X., Ding, P., Wang, L., Sun, Y., Li, S., Zhang, H., & Gao, Z. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.06.059 · Cited by 35
Edgington, R. J., Spillane, K. M., Papageorgiou, G., Wray, W., Ishiwata, H., Labarca, M., Leal‐Ortiz, S., Reid, G., Webb, M. R., Foord, J. S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-18601-6 · Cited by 31
Bi, Y., Zhang, Y., Cui, C., Ren, L., & Jiang, X. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s117611 · Cited by 29
de Garibay, A. P. R., Solinís, M. Á., Rodríguez‐Gascón, A., Ganjian, H., & Fuchs, R. (2013) · The Journal of Gene Medicine · doi:10.1002/jgm.2749 · Cited by 28
Villate-Beitia, I., Puras, G., Soto‐Sánchez, C., Agirre, M., Ojeda, E., Sesma, J. Z., Fernández, E., & Pedraz, J. L. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.02.016 · Cited by 26
Self-citation
Cited by
Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions
Drag, S., Dotiwala, F., & Upadhyay, A. K. (2023) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.64.7.39 · Cited by 145
Gout therapeutics and drug delivery
Peng, X., Li, X., Xie, B., Lai, Y., Sosnik, A., Boucetta, H., Chen, Z., & He, W. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.09.011 · Cited by 77
Carbon-Based Nanostructures as Emerging Materials for Gene Delivery Applications
Yazdani, S., Mozaffarian, M., Pazuki, G., Hadidi, N., Villate-Beitia, I., Sesma, J. Z., Puras, G., & Pedraz, J. L. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16020288 · Cited by 65
Self-citationNanodiamonds in biomedical research: Therapeutic applications and beyond
Alexander, E., & Leong, K. W. (2024) · PNAS Nexus · doi:10.1093/pnasnexus/pgae198 · Cited by 38
Versatile nanodiamond-based tools for therapeutics and bioimaging
Leung, H. M., Chu, H. C., Mao, Z., & Lo, P. K. (2023) · Chemical Communications · doi:10.1039/d2cc06495b · Cited by 29
Metadata
- Authors
- AL Qtaish, N., Gallego, I., Paredes, A. J., Villate-Beitia, I., Soto-Sánchez, C., Martínez-Navarrete, G., Sainz-Ramos, M., Lopez-Mendez, T. B., Fernández, E., Puras, G., & Pedraz, J. L.
- Affiliations
- NanoBioCel Research Group, Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain
- University of the Basque Country (ES)
- Queen's University Belfast (GB)
- Networking Research Centre of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Institute of Health Carlos III, 28029 Madrid, Spain
- Universitat de Miguel Hernández d'Elx (ES)
- Corresponding author
- Puras, Gustavo
- ORCID
- Venue
- ACS Applied Materials & Interfaces
- Publisher
- American Chemical Society (ACS)
- Published
- 2022-03-15
- Volume
- 14
- Issue
- 11
- Pages
- 13665-13677
- ISSN
- 1944-8244 (ISSN-L)
- 1944-8252
- PMC
- PMC8949757
- OpenAlex
- W4220840779
- Cited by
- 29
- References
- 57
- Citations by year
- 2026: 6 · 2025: 3 · 2024: 11 · 2023: 8 · 2022: 1
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- ACS Applied Materials & Interfaces (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Communities in ADDI (University of the Basque Country) (submittedVersion, cc-by)
- Hispana (submittedVersion, cc-by)
- Research Portal (Queen's University Belfast) (submittedVersion, cc-by)
- Greater South Information System
- Funders
- Centro de Investigaci?n Biom?dica en Red en Bioingenier?a, Biomateriales y Nanomedicina
- Eusko Jaurlaritza (IT907-16)
- Euskal Herriko Unibertsitatea (ESPDOC19/47, PIF17/79)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Materials Science › Materials Chemistry › Diamond and Carbon-based Materials Research
- Keywords
- nanodiamonds, niosomes, non-viral gene delivery, central nervous system disorders, transfection efficiency, cellular uptake, endocytosis, clathrin-mediated endocytosis, caveolae, lysosomal escape, biocompatibility, neurons, retinal cells
- MeSH terms
- Central Nervous System Diseases, Humans, Liposomes, Plasmids, Genetic Therapy, HEK293 Cells, Nanodiamonds
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.